Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Avastin in metastatic pancreatic cancer
NCT01214720Phase 3Completed
- Sponsor
- Roche
- Start
- Jul 2005
- Primary completion
- Oct 2008
- Modality
- Monoclonal Antibodies
- Countries
- 21
01
Overview
A Phase 3 trial of bevacizumab, sponsored by Roche. Started Jul 2005; status: completed.
02
Drugs
bevacizumab
Beyond the preview
Go deeper on NCT01214720.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01214720.